News / Taiwan / economic_daily
ScinoPharm Q3 Earnings Mixed, Expects Q4 Growth from New Ertapenem Line
Health Technology · Pharmaceuticals: Major · economic_daily · 2026-11-05
4167
ScinoPharm reported a 70% year-over-year increase in net profit for the first nine months, driven by investment gains, and anticipates Q4 revenue growth from its new production capacity.
What Happened
Financial Results: ScinoPharm reported Q3 revenue of NT$319 million, an 11% sequential increase, but posted a net loss of NT$98.85 million due to financial valuation losses. Despite the quarterly loss, the company's net profit for the first three quarters reached NT$763 million, a 70.1% increase year-over-year, with EPS of NT$2.3.
Non-Operating Gains: While core operating revenue and margins declined during the first nine months, the company achieved strong bottom-line growth. Management attributed this performance to successful diversified investment strategies, which significantly bolstered overall profitability.
Capacity Expansion: The new Ertapenem production line, which received GMP certification in June, has doubled the company's capacity. ScinoPharm is leveraging this to capture international market share as global supply chains undergo structural shifts and demand for stable drug supplies increases.
Outlook: The company expects Q4 revenue to grow as new capacity scales up to meet global demand. ScinoPharm remains focused on expanding its antibiotic product footprint in international hospital systems and diversifying its business through its healthcare subsidiary.
Read original
More in Health Technology
Health Technology · economic_daily · 2026-11-05
Lotus Pharmaceutical shares climbed over 5% today as investor sentiment in the biotech sector improved following the U.S. election, supported by strong foreign buying.
1795
Health Technology · economic_daily · 2026-11-05
PharmaEssentia reported record-high October revenue of 2.84 billion TWD, driven by robust U.S. sales of its Ropeg injection pen and expansion into the ET market.
6446
Health Technology · economic_daily · 2026-11-05
US healthcare stocks surged on expectations of favorable policy continuity following Democratic election gains, fueling a rally in Taiwan's biotech sector, led by strong earnings and new product approvals from companies like Bora Pharmaceuticals.
1786, 1795, 6446, 6472, 6782, 6919, 6949
Latest in Taiwan
Electronic Technology · economic_daily · 2026-11-05
Morgan Stanley issued a report on AMD's latest earnings, highlighting a divergence in the supply chain between robust server CPU demand and a weakening PC market.
2324, 2353, 2357, 2368, 2383, 2474, 3037, 3533, 6274, 6669, 8046, 8358
Electronic Technology · economic_daily · 2026-11-05
Memory module leader Transcend reported record-breaking earnings for the first nine months of 2026, driven by strong demand in AI and data center sectors.
Electronic Technology · economic_daily · 2026-11-05
Asia Optical (3019) shares hit the daily limit despite a broader market decline, fueled by a 61% year-over-year profit jump and progress in CPO and robotics.
Transportation · economic_daily · 2026-11-05
EVA Air saw its stock price climb 3.09% to close at 45.1 TWD, supported by strong foreign buying and increased trading volume as AI-related demand boosts market sentiment.
2618